Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Human Erythropoietin Injection

Approval Number

国药准字S20133004

Company深圳赛保尔生物药业有限公司

Registration Date

April 26, 2024

Drug Information

Generic Name

人促红素注射液

Trade Name

赛博尔

Dosage Form

注射剂

Strength

2500IU/0.5ml/支

Drug Type

生物制品

Registration Date

April 26, 2024

Company Information

Applicant Company

Company Name深圳赛保尔生物药业有限公司

Company Address

深圳市龙岗区坂田街道雅园路14号

Manufacturing Company

Company Name深圳赛保尔生物药业有限公司

Company Address

深圳市龙岗区坂田街道雅园路14号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy